Women's Health

GLP-1 receptor agonists show promise in alleviating PCOS symptoms, including weight loss and menstrual regulation, despite needing further research.

A maternal inflammatory diet during pregnancy raises the risk of offspring developing type 1 diabetes, highlighting the impact of nutrition on early health.

When no contraindications are present, most cases can be managed well with nonsteroidal anti-inflammatory drugs.

Significant challenges persist, particularly in low- and middle-income countries.

A clinical trial shows tebipenem pivoxil hydrobromide (Tebipenem HBr; Spero Therapeutics and GSK) effectively treats complicated urinary tract infections (cUTIs), potentially transforming patient care and reducing hospital costs.

IVIG treatment significantly boosts platelet counts in pregnant people with thrombocytopenia, revealing key predictors for effective response and optimizing clinical decisions.

The risk of cardiovascular disease (CVD) was higher among those who were exposed to assisted reproductive technology.

The treatment could hold significant potential for major depressive disorder

The new guidelines urge health care professionals to offer local anesthetics and other medications for intrauterine device (IUD) insertions and other gynecologic procedures.

The new at-home test aims to increase comfort and screening timeliness through a more accessible method.

With the FDA approval, avutometinib/defactinib is now the first and only FDA-approved treatment for patients with recurrent low-grade serous ovarian cancer (LGSOC).

Research reveals that higher levels of vitamin B12, copper, and manganese during pregnancy lower midlife blood pressure and hypertension risk.

Promoting weight management prior to pregnancy and in early life may yield stronger cardiovascular and maternal health.

Gepotidacin is indicated for female patients who are at least 12 years of age and weigh at least 40 kg with uncomplicated urinary tract infections (uUTIs) caused by certain microorganisms.

Contraceptive options have expanded since 1960, with pharmacists today playing a growing role as prescribers of contraception and studies showing the benefit of pharmacist-driven contraception clinics.

Compared with daily oral iron, a single intravenous (IV) infusion of iron was shown to lower rates of low birth weight in infants and decrease reliance on further iron supplementation or transfusions in pregnant patients with anemia.

Panelists discuss how menopause care requires a holistic, patient-centered approach involving thorough medical assessment, interdisciplinary collaboration, personalized risk management, and comprehensive support addressing physical, psychological, and preventive health care needs.

Panelists highlight how effective communication requires health care professionals to demonstrate empathy, actively listen, provide evidence-based information, and develop individualized treatment strategies that address the physical and psychological aspects of the menopausal transition.

If approved, gepotidacin (GSK) will be a new oral agent added to the treatment paradigm for urinary tract infections (UTIs).

Radon exposure during pregnancy was significantly linked to increased odds of gestational diabetes.

Panelists discuss how health care professionals recommend physician consultations for persistent symptoms, complex medical histories, diagnostic uncertainties, specialist needs, urgent conditions, preventive care, medication management, and comprehensive health assessments.

Panelists explain how health care professionals evaluate menopause symptoms using validated questionnaires, symptom tracking, clinical interviews, hormonal tests, and patient-reported outcome measures to comprehensively assess severity and quality-of-life impact.

Pharmacists must consider drug Interactions, allergies, and comorbidities when treating patients with urinary tract infections (UTIs).